Rockefeller Capital Management
VIR icon

Rockefeller Capital Management’s Vir Biotechnology VIR Stock Holding History

Rockefeller Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Buy
39,323
+9,454
+32% +$75.3K ﹤0.01% 2168
2025
Q4 		$180K Buy
29,869
+19,472
+187% +$116K ﹤0.01% 2429
2025
Q3 		$59.4K Buy
+10,397
New +$53.2K ﹤0.01% 2822
2023
Q1 		– Sell
-4,726
Closed -$119K – 3826
2022
Q4 		$119K Sell
4,726
-47
-1% -$1.15K ﹤0.01% 1941
2022
Q3 		$92K Buy
4,773
+4,652
+3,845% +$118K ﹤0.01% 2035
2022
Q2 		$3K Buy
+121
New +$2.83K ﹤0.01% 3708
2021
Q3 		– Sell
-13,832
Closed -$653K – 3856
2021
Q2 		$653K Hold
13,832
– – ﹤0.01% 1090
2021
Q1 		$709K Buy
13,832
+9,001
+186% +$485K ﹤0.01% 908
2020
Q4 		$129K Buy
+4,831
New +$157K ﹤0.01% 1345

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Rockefeller Capital Management's VIR Position: Q1 2026 in Review

Rockefeller Capital Management increased its Vir Biotechnology (VIR) stake by 32% in Q1 2026, buying an estimated $75.3K and bringing the position to 39,323 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Rockefeller Capital Management first reported a position in VIR in Q4 2020 and has held it in 9 quarters since. The position peaked at $709K in Q1 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Rockefeller Capital Management held 39,323 shares of Vir Biotechnology worth $352K as of Q1 2026.
  • Rockefeller Capital Management bought 9,454 Vir Biotechnology shares in Q1 2026, an estimated $75.3K.
  • Vir Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2168 holding.
  • Rockefeller Capital Management first reported a position in Vir Biotechnology in Q4 2020 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Vir Biotechnology position peaked at $709K in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.